Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow IMPACT BIOMEDICAL INC.

Get SEC filing alerts via email and in your feed for IMPACT BIOMEDICAL INC.

IBO

IMPACT BIOMEDICAL INC.

About IMPACT BIOMEDICAL INC.

Impact BioMedical Inc. is a biotech company focused on discovering, developing, and licensing innovative technologies for human healthcare and wellness. Its core activities include biopharmaceuticals, consumer wellness products, and drug discovery targeting neurological, oncologic, and inflammatory diseases. The company leverages proprietary science, strategic partnerships, and intellectual property to commercialize solutions through licensing and direct sales, addressing unmet medical needs globally.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from IMPACT BIOMEDICAL INC.

1
1
IMPACT BIOMEDICAL INC. Impact BioMedical Reports $7,000 Revenue in Q1 2026, Faces Increased Losses

Via official filing (AI summary) | 23 days ago | 0 comments

2
1
IMPACT BIOMEDICAL INC. Impact Biomedical Reports First Revenue of $32,000 and Significant Net Loss Reduction for Fiscal Year 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
IMPACT BIOMEDICAL INC. Impact BioMedical Reports Financial Challenges with $1.47M Net Loss in Latest Quarter

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
IMPACT BIOMEDICAL INC. Impact BioMedical Reports $1.15M Operating Loss and $15.63M Net Loss for Quarter Ending June 30, 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
IMPACT BIOMEDICAL INC. Impact BioMedical Reports $1.278 Million Net Loss in Q1 2025, Increases Costs and Acquires Assets

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
IMPACT BIOMEDICAL INC. Impact Biomedical Inc. Reports $24.77 Million Net Loss in 2024 Fiscal Year

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
IMPACT BIOMEDICAL INC. Impact BioMedical Reports Significant Turnaround, Net Income of $4.2M in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments